Djibouti vs Sur: New cases tested for RR-/MDR-TB
Djibouti
100.0%
in 2022
Sur
97.0%
in 2024
Djibouti rank
1st
Sur rank
2nd
New cases tested for RR-/MDR-TB over time
- Djibouti
- Sur
How they compare
Djibouti currently reports 100.0% against 97.0% in Sur, a difference of 3.0%.
The two have swapped places 5 times across 9 shared years of data; in 2005 it was Sur ahead.
Djibouti ranks 1st and Sur ranks 2nd of 192 countries.
Across the 3 decades both report, Djibouti averaged higher in 1 and Sur in 2.
Head to head by decade
| Decade | Djibouti | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 44.0% | 44.0% | Sur |
| 2010s | 65.7% | 87.7% | 22.0% | Sur |
| 2020s | 100.0% | 97.0% | 3.0% | Djibouti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Djibouti or Sur?
- Djibouti, at 100.0% against 97.0% in Sur as of 2022.
- What is the difference in new cases tested for rr-/mdr-tb between Djibouti and Sur?
- 3.0%, with Djibouti ahead.
- How many years of comparable data are there for Djibouti and Sur?
- 9 years are reported by both, from 2005 to 2022.
- How do Djibouti and Sur rank globally for new cases tested for rr-/mdr-tb?
- Djibouti ranks 1st and Sur ranks 2nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.